0001493152-24-033342.txt : 20240820
0001493152-24-033342.hdr.sgml : 20240820
20240820205952
ACCESSION NUMBER: 0001493152-24-033342
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240815
FILED AS OF DATE: 20240820
DATE AS OF CHANGE: 20240820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CURHAN GREGORY S
CENTRAL INDEX KEY: 0001263244
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38519
FILM NUMBER: 241226975
MAIL ADDRESS:
STREET 1: 600 CALIFORNIA STREET, 9TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Serina Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821436829
STATE OF INCORPORATION: AL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
BUSINESS PHONE: (256) 327-9630
MAIL ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
FORMER COMPANY:
FORMER CONFORMED NAME: AgeX Therapeutics, Inc.
DATE OF NAME CHANGE: 20170606
3
1
ownership.xml
X0206
3
2024-08-15
1
0001708599
Serina Therapeutics, Inc.
SER
0001263244
CURHAN GREGORY S
601 GENOME WAY, SUITE 2001
HUNTSVILLE
AL
35806
0
1
0
0
Chief Financial Officer
/s/ Gregory S. Curhan
2024-08-20